0001042187 2026-01-01 2026-06-30 0001042187 2026-08-07 0001042187 2026-06-30 0001042187 2025-12-31 0001042187 us-gaap:NonrelatedPartyMember 2026-06-30 0001042187 us-gaap:NonrelatedPartyMember 2025-12-31 0001042187 us-gaap:RelatedPartyMember 2026-06-30 0001042187 us-gaap:RelatedPartyMember 2025-12-31 0001042187 us-gaap:SeriesEPreferredStockMember 2026-06-30 0001042187 us-gaap:SeriesEPreferredStockMember 2025-12-31 0001042187 us-gaap:SeriesFPreferredStockMember 2026-06-30 0001042187 us-gaap:SeriesFPreferredStockMember 2025-12-31 0001042187 2025-10-01 2025-10-01 0001042187 2026-04-01 2026-06-30 0001042187 2025-04-01 2025-06-30 0001042187 2025-01-01 2025-06-30 0001042187 2024-12-31 0001042187 2025-06-30 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001042187 us-gaap:CommonStockMember 2025-12-31 0001042187 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001042187 us-gaap:RetainedEarningsMember 2025-12-31 0001042187 us-gaap:TreasuryStockCommonMember 2025-12-31 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2026-03-31 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2026-03-31 0001042187 us-gaap:CommonStockMember 2026-03-31 0001042187 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001042187 us-gaap:RetainedEarningsMember 2026-03-31 0001042187 us-gaap:TreasuryStockCommonMember 2026-03-31 0001042187 2026-03-31 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2024-12-31 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2024-12-31 0001042187 us-gaap:CommonStockMember 2024-12-31 0001042187 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001042187 us-gaap:RetainedEarningsMember 2024-12-31 0001042187 us-gaap:TreasuryStockCommonMember 2024-12-31 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-03-31 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-03-31 0001042187 us-gaap:CommonStockMember 2025-03-31 0001042187 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001042187 us-gaap:RetainedEarningsMember 2025-03-31 0001042187 us-gaap:TreasuryStockCommonMember 2025-03-31 0001042187 2025-03-31 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001042187 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001042187 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001042187 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001042187 us-gaap:TreasuryStockCommonMember 2026-01-01 2026-03-31 0001042187 2026-01-01 2026-03-31 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2026-04-01 2026-06-30 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2026-04-01 2026-06-30 0001042187 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001042187 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001042187 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001042187 us-gaap:TreasuryStockCommonMember 2026-04-01 2026-06-30 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001042187 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001042187 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001042187 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001042187 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0001042187 2025-01-01 2025-03-31 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-04-01 2025-06-30 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-04-01 2025-06-30 0001042187 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001042187 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001042187 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001042187 us-gaap:TreasuryStockCommonMember 2025-04-01 2025-06-30 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2026-06-30 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2026-06-30 0001042187 us-gaap:CommonStockMember 2026-06-30 0001042187 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001042187 us-gaap:RetainedEarningsMember 2026-06-30 0001042187 us-gaap:TreasuryStockCommonMember 2026-06-30 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-06-30 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-06-30 0001042187 us-gaap:CommonStockMember 2025-06-30 0001042187 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001042187 us-gaap:RetainedEarningsMember 2025-06-30 0001042187 us-gaap:TreasuryStockCommonMember 2025-06-30 0001042187 us-gaap:RevolvingCreditFacilityMember YHGJ:NewCreditAgreementsMember 2025-09-30 0001042187 YHGJ:TermLoanMember YHGJ:NewCreditAgreementsMember 2025-09-30 0001042187 us-gaap:RevolvingCreditFacilityMember YHGJ:LineFinancialAgreementMember 2021-09-30 0001042187 YHGJ:TermLoanMember YHGJ:LineFinancialAgreementMember 2021-09-30 0001042187 us-gaap:RevolvingCreditFacilityMember YHGJ:LineFinancialAgreementMember 2026-06-30 0001042187 YHGJ:TermLoanMember YHGJ:LineFinancialAgreementMember 2026-06-30 0001042187 YHGJ:LineFinancialAgreementMember 2021-09-30 2021-09-30 0001042187 YHGJ:LineFinancialAgreementMember 2025-09-30 2025-09-30 0001042187 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember YHGJ:LineFinancialAgreementMember 2025-09-30 0001042187 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember YHGJ:LineFinancialAgreementMember 2025-09-30 0001042187 us-gaap:RevolvingCreditFacilityMember YHGJ:LineFinancialAgreementMember 2025-09-30 0001042187 YHGJ:LineFinancialAgreementMember 2026-01-01 2026-06-30 0001042187 YHGJ:TermLoanMember YHGJ:LineFinancialAgreementMember 2025-12-31 0001042187 us-gaap:RevolvingCreditFacilityMember YHGJ:LineFinancialAgreementMember 2025-12-31 0001042187 YHGJ:JohnHSchwanMember 2023-12-31 0001042187 YHGJ:JohnHSchwanMember 2024-01-01 2024-01-31 0001042187 YHGJ:JohnHSchwanMember 2026-06-30 0001042187 us-gaap:SeriesEPreferredStockMember 2026-01-01 2026-06-30 0001042187 us-gaap:SeriesFPreferredStockMember 2026-01-01 2026-06-30 0001042187 us-gaap:WarrantMember 2026-06-30 0001042187 YHGJ:SeriesEandSeriesFPreferredStockMember 2026-06-30 0001042187 us-gaap:WarrantMember 2025-12-31 0001042187 us-gaap:WarrantMember 2026-01-01 2026-06-30 0001042187 YHGJ:TwoThousandAndTwentyFiveCommonStockWarrantsMember 2026-06-30 0001042187 us-gaap:PreferredStockMember 2026-06-30 0001042187 YHGJ:RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember 2025-12-31 0001042187 YHGJ:RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember 2026-01-01 2026-06-30 0001042187 YHGJ:RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember 2026-06-30 0001042187 YHGJ:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2026-04-01 2026-06-30 0001042187 YHGJ:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-04-01 2025-06-30 0001042187 YHGJ:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2026-04-01 2026-06-30 0001042187 YHGJ:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-04-01 2025-06-30 0001042187 YHGJ:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-06-30 0001042187 YHGJ:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-06-30 0001042187 YHGJ:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-06-30 0001042187 YHGJ:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-06-30 0001042187 YHGJ:JohnHSchwanMember 2025-12-31 0001042187 YHGJ:IcyMelonLLCMember 2025-01-13 2025-01-13 0001042187 YHGJ:IcyMelonLLCMember 2026-04-01 2026-06-30 0001042187 YHGJ:IcyMelonLLCMember 2025-04-01 2025-06-30 0001042187 YHGJ:IcyMelonLLCMember 2026-06-30 0001042187 YHGJ:IcyMelonLLCMember 2025-12-31 0001042187 YHGJ:IcyMelonLLCMember 2025-01-01 2025-12-31 0001042187 YHGJ:IcyMelonLLCMember 2026-01-01 2026-06-30 0001042187 srt:MinimumMember 2026-06-30 0001042187 srt:MaximumMember 2026-06-30 iso4217:USD shares iso4217:USD shares pure YHGJ:Segment false --12-31 Q2 0001042187

10-Q true 2026-06-30 2026 false 000-23115 YUNHONG GREEN CTI LTD. IL 36-2848943 22160 N. Pepper Road Barrington IL 60010 (847) 382-1000 Common Stock, no par value per share YHGJ NASDAQ Yes Yes Non-accelerated Filer true false false 2609244

320000

97000

3295000

5955000

7827000

8738000

351000

283000

11793000

15073000

21993000

2122000

783000 783000

39000

518000

170000

140000

25625000

25595000

21885000

21599000

3740000

3996000

3087000

3393000

3087000 3393000

18620000

22462000

1482000

1677000

4591000

6822000

443000

146000

344000

659000

596000

225000 150000

627000

950000

8371000

10685000

348000

2526000

2873000

2526000

3221000

10897000

13906000

130000

1300000

1032000

976000

70000

700000

555000

525000

555000

525000

2000000000

2613670

2601788

2609244

2597362

27891000

7676000

7711000

-29270000

-28386000

4426

161000

7723000

8556000

18620000

22462000

1-for-10

3900000

5457000

10054000

10259000

3362000

4479000

8502000

8415000

538000

978000

1552000

1844000

675000

754000

1598000

1593000

34000

37000

71000

72000

149000

168000

302000

338000

858000

959000

1971000

2003000

-320000

19000

-419000

-159000

225000

227000

467000

465000

2000

23000

2000

23000

-223000

-204000

-465000

-442000

-543000

-185000

-884000

-601000

43000

86000

-586000

-228000

-970000

-687000

-0.22

-0.09

-0.37

-0.26

-0.22

-0.09

-0.37

-0.26

2608638

2608082

2604856

2608082

2608638

2608082

2604856

2608082

1-for-10

-884000

-601000

286000

322000

51000

17000

-2660000

-1608000

-911000

-313000

68000

-169000

-195000

-104000

22000

40000

75000

-323000

-50000

2535000

1714000

30000

42000

-30000

-42000

51000

42000

-2231000

-1832000

-2282000

-1874000

223000

-202000

97000

220000

320000

18000

467000

465000

86000

1050000 182000

1-for-10

130000

976000

70000

525000

2601788

27891000

7711000

-28386000

-4426

-161000

8556000

28000 -28000 15000 -15000

6917

38000

6000

-341000

130000

1004000

70000

540000

2608705

27891000

7712000

-28727000

-4426

-161000

8259000

28000 -28000 15000 -15000

4965

7000

-543000

130000

1032000

70000

555000

2613670

27891000

7676000

-29270000

-4426

-161000

7723000

130000

864000

70000

465000

2599185

27533000

7858000

-25856000

-4426

-161000

10703000

28000 -28000 15000 -15000

27604

182000

9000

-416000

130000

892000

70000

480000

2626789

27715000

7824000

-26272000

-4426

-161000

10478000

28000 -28000 15000 -15000 150000 1050000 1050000

8000

-185000

130000

920000

70000

495000

2776789

28765000

7789000

-26457000

-4426

-161000

11351000

1-for-10

<p id="xdx_80A_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zjldrvZDiGl9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Note 1 - Basis of Presentation and Significant Accounting Policies The accompanying unaudited condensed consolidated interim financial statements have been prepared and, in the opinion of management, contain all material adjustments (consisting of those of a normal recurring nature) considered necessary to present fairly the consolidated financial position and the consolidated statements of loss and consolidated cash flows for the periods presented in conformity with generally accepted accounting principles for interim consolidated financial information and the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America. Operating results for the three and six months ended June 30, 2026 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2026. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2025, filed on March 23, 2026, which can be found on the Company’s website (www.ctiindustries.com) or www.sec.gov. The financial information presented in these financial statements has been rounded to the nearest thousand dollars ($000), which is in accordance with our policy to simplify the presentation. The financial information is not presented in thousand-dollar increments. All of the Company’s historical share and per share information related to issued and outstanding common stock, outstanding share based awards and warrants exercisable for common stock in these financial statements have been adjusted, on a retroactive basis, to reflect the 1-for-10 reverse stock split approved by the Company’s shareholders on August 22, 2025 and effective October 1, 2025. Principles of consolidation and nature of operations: Yunhong Green CTI Ltd., its wholly owned subsidiary Yunhong Technology Industry (Hubei) Co., Ltd., and its inactive subsidiary CTI Supply, Inc. (collectively, the “Company”) (i) design, manufacture and distribute metalized balloon products throughout the world, (ii) distribute purchased latex balloons products, and (iii) operate systems for the production, lamination, coating and printing of films used for food packaging and other commercial uses and for conversion of films to flexible packaging containers and other products. The condensed consolidated financial statements include the accounts of Yunhong Green CTI Ltd., CTI Supply, Inc., and Yunhong Technology Industry (Hubei) Co., Ltd. All intercompany accounts and transactions have been eliminated in consolidation. See Note 2 to the consolidated financial statements included in Form 10-K for the fiscal year ended December 31, 2025. Use of estimates: In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions that affect the amounts reported of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period in the financial statements and accompanying notes. Actual results may differ from those estimates. The Company’s significant estimates include recoverability and impairment of long-lived assets, valuation allowances for doubtful accounts, inventory valuation and valuation of deferred tax assets. Segments: The Company views its operations and manages its business as one segment, both in terms of geography and operations. All manufacturing occurs in the United States. Due to the single reportable segment, this financial information is presented on the Consolidated Statements of Loss. There are no significant segment expenses reported to the chief operating decision maker (CODM), which is the Chief Executive Officer. The Company’s CODM regularly reviews financial information presented and does not evaluate the Company’s operating segment using asset or liability information. Instead, the CODM uses revenue, gross margin, and net income or loss to allocate operating and capital resources and assess performance by comparing actual results to historical results and previously forecasted financial information. Earnings per share: Basic (loss) per share is computed by dividing net loss attributable to common shareholders by the weighted average number of shares of common stock outstanding during each period. Diluted (loss) per share is computed by dividing the net loss attributable to common shareholders by the weighted average number of shares of common stock and equivalents (stock options and warrants), unless anti-dilutive, during each period. In periods for which there is a net loss, diluted loss per common share is equal to basic loss per common share, since the effect of including any common stock equivalents would be antidilutive. For both June 30, 2026 and 2025 , shares to be issued upon the exercise of warrants aggregated 55,600. No options were outstanding for the three months ended June 30, 2026 and 2025. The number of shares included in the determination of earnings on a diluted basis for the three months ended June 30, 2026 and 2025 were none, as doing so would have been anti-dilutive. Revenue recognition: Net sales include revenues from sales of products and shipping and handling charges, net of estimates for product returns. Revenue is measured at the amount of consideration the Company expects to receive in exchange for the transferred products. Revenue is recognized at the point in time when we transfer the promised products to the customer and the customer obtains control over the products. The Company recognizes revenue for shipping and handling charges at the time the goods are shipped to the customer, and the costs of outbound freight are included in cost of sales, as we have elected the practical expedient included in ASC 606. The Company provides for product returns based on historical return rates. While we incur costs for sales commissions to our sales employees and outside agents, we recognize commission costs concurrent with the related revenue, as the amortization period is less than one year and we have elected the practical expedient included in ASC 606. We do not incur incremental costs to obtain contracts with our customers. Our product warranties are assurance-type warranties, which promise the customer that the products are as specified in the contract. Therefore, the product warranties are not a separate performance obligation and are accounted for as described herein. Sales taxes assessed by governmental authorities are accounted for on a net basis and are excluded from net sales.

1-for-10

Principles of consolidation and nature of operations: Yunhong Green CTI Ltd., its wholly owned subsidiary Yunhong Technology Industry (Hubei) Co., Ltd., and its inactive subsidiary CTI Supply, Inc. (collectively, the “Company”) (i) design, manufacture and distribute metalized balloon products throughout the world, (ii) distribute purchased latex balloons products, and (iii) operate systems for the production, lamination, coating and printing of films used for food packaging and other commercial uses and for conversion of films to flexible packaging containers and other products. The condensed consolidated financial statements include the accounts of Yunhong Green CTI Ltd., CTI Supply, Inc., and Yunhong Technology Industry (Hubei) Co., Ltd. All intercompany accounts and transactions have been eliminated in consolidation. See Note 2 to the consolidated financial statements included in Form 10-K for the fiscal year ended December 31, 2025.

Use of estimates: In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions that affect the amounts reported of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period in the financial statements and accompanying notes. Actual results may differ from those estimates. The Company’s significant estimates include recoverability and impairment of long-lived assets, valuation allowances for doubtful accounts, inventory valuation and valuation of deferred tax assets.

Segments: The Company views its operations and manages its business as one segment, both in terms of geography and operations. All manufacturing occurs in the United States. Due to the single reportable segment, this financial information is presented on the Consolidated Statements of Loss. There are no significant segment expenses reported to the chief operating decision maker (CODM), which is the Chief Executive Officer. The Company’s CODM regularly reviews financial information presented and does not evaluate the Company’s operating segment using asset or liability information. Instead, the CODM uses revenue, gross margin, and net income or loss to allocate operating and capital resources and assess performance by comparing actual results to historical results and previously forecasted financial information.

Earnings per share: Basic (loss) per share is computed by dividing net loss attributable to common shareholders by the weighted average number of shares of common stock outstanding during each period. Diluted (loss) per share is computed by dividing the net loss attributable to common shareholders by the weighted average number of shares of common stock and equivalents (stock options and warrants), unless anti-dilutive, during each period. In periods for which there is a net loss, diluted loss per common share is equal to basic loss per common share, since the effect of including any common stock equivalents would be antidilutive. For both June 30, 2026 and 2025 , shares to be issued upon the exercise of warrants aggregated 55,600. No options were outstanding for the three months ended June 30, 2026 and 2025. The number of shares included in the determination of earnings on a diluted basis for the three months ended June 30, 2026 and 2025 were none, as doing so would have been anti-dilutive.

55600

Revenue recognition: Net sales include revenues from sales of products and shipping and handling charges, net of estimates for product returns. Revenue is measured at the amount of consideration the Company expects to receive in exchange for the transferred products. Revenue is recognized at the point in time when we transfer the promised products to the customer and the customer obtains control over the products. The Company recognizes revenue for shipping and handling charges at the time the goods are shipped to the customer, and the costs of outbound freight are included in cost of sales, as we have elected the practical expedient included in ASC 606. The Company provides for product returns based on historical return rates. While we incur costs for sales commissions to our sales employees and outside agents, we recognize commission costs concurrent with the related revenue, as the amortization period is less than one year and we have elected the practical expedient included in ASC 606. We do not incur incremental costs to obtain contracts with our customers. Our product warranties are assurance-type warranties, which promise the customer that the products are as specified in the contract. Therefore, the product warranties are not a separate performance obligation and are accounted for as described herein. Sales taxes assessed by governmental authorities are accounted for on a net basis and are excluded from net sales.

Note 2 – Liquidity and Going Concern The Company’s financial statements are prepared using accounting principles generally accepted in the United States (“U.S. GAAP”) applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has a cumulative net loss from inception to June 30, 2026 of approximately $29 million. The accompanying financial statements for the three months ended June 30, 2026 have been prepared assuming the Company will continue as a going concern. Existing cash resources and cash expected to be generated from operations are not expected to be sufficient to fund the Company’s anticipated operating requirements over the next twelve months without additional financing. The ability of the Company to continue as a going concern is dependent on the Company having adequate capital to fund its operating plan and performance. Management’s plans to continue as a going concern include raising additional capital , including through a potential registered offering of equity securities, as well as borrowings, continuing to focus on attaining profitable operations, and exploring alternative funding sources on an as needed basis. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. The supply chain challenges, inflationary pressures and tariffs have impacted on the Company’s business operations to some extent and is expected to continue to do so and these impacts may include reduced access to capital. The ability of the Company to continue as a going concern may be dependent upon its ability to successfully secure other sources of financing and attain profitable operations. There is substantial doubt about the ability of the Company to continue as a going concern for one year from the issuance of the accompanying consolidated financial statements. The accompanying consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. The Company’s primary sources of liquidity have traditionally been comprised of cash and cash equivalents as well as availability under a Credit Agreement. The Credit Agreement with Line Financial, as most recently amended in September 2025, includes a revolving credit facility for up to $<span id="xdx_90A_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn6n6_c20250930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--TypeOfArrangementAxis__custom--NewCreditAgreementsMember_zYVNXnIxYCjb" title="Line of credit facility, maximum borrowing capacity">7 million and a term loan of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20250930__us-gaap--TypeOfArrangementAxis__custom--NewCreditAgreementsMember__us-gaap--LongtermDebtTypeAxis__custom--TermLoanMember_zbqnsbXxu56c" title="Debt instrument face amount">0.7 million, all supported by the majority of our assets. This Agreement was extended during September 2025, to mature April 30, 2027, under substantially similar terms.

29000000

7000000

700000

Note 3 - Debt Senior Facilities On September 30, 2021 (the “Closing Date”), the Company entered into a loan and security agreement (the “Agreement”) with Line Financial (the “Lender”), which provides for a senior secured financing consisting of a revolving credit facility (the “Revolving Credit Facility) in an aggregate principal amount of up to $<span id="xdx_903_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn6n6_c20210930__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--TypeOfArrangementAxis__custom--LineFinancialAgreementMember_zama9r6d73f" title="Maximum revolver amount">7 million, as amended (the “Maximum Revolver Amount”), subject to borrowing base provisions, and term loan facility (the “Term Loan Facility”) in an aggregate principal amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20210930__us-gaap--CreditFacilityAxis__custom--TermLoanMember__us-gaap--TypeOfArrangementAxis__custom--LineFinancialAgreementMember_zCIDjejvnctg" title="Term loan amount">731,250 (“Term Loan Amount” and, together with the Revolving Credit Facility, the “Senior Facilities”). The Senior Facilities are secured by substantially all assets of the Company. The Company has remained in compliance with all material covenants since inception. Borrowings under the Revolving Credit Facility bear interest at the prime rate + <span id="xdx_90E_ecustom--DebtInstrumentReferenceRate_iI_pid_dp_uPure_c20210930__us-gaap--TypeOfArrangementAxis__custom--LineFinancialAgreementMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_z71AC6zmcFw4" title="Debt instrument interest rate">7.82% (<span id="xdx_90B_ecustom--DebtInstrumentReferenceRate_iI_pid_dp_uPure_c20260630__us-gaap--TypeOfArrangementAxis__custom--LineFinancialAgreementMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zvQbPFcwH6ke" title="Debt instrument interest rate">14.57% as of June 30, 2026), payable monthly in arrears. The Term Loan Facility bears interest at the prime rate + <span id="xdx_90E_ecustom--DebtInstrumentReferenceRate_iI_pid_dp_uPure_c20210930__us-gaap--TypeOfArrangementAxis__custom--LineFinancialAgreementMember__us-gaap--CreditFacilityAxis__custom--TermLoanMember_zHeDLUAJo2I3" title="Iinterest rate">1.45% (<span id="xdx_90F_ecustom--DebtInstrumentReferenceRate_iI_pid_dp_uPure_c20260630__us-gaap--TypeOfArrangementAxis__custom--LineFinancialAgreementMember__us-gaap--CreditFacilityAxis__custom--TermLoanMember_zsJD8pIdnUNg" title="Prime interest rate">8.2% as of June 30, 2026) and is repaid in <span id="xdx_903_eus-gaap--DebtInstrumentFrequencyOfPeriodicPayment_c20210930__20210930__us-gaap--TypeOfArrangementAxis__custom--LineFinancialAgreementMember_z8Wx9uH3SDr2" title="Periodic monthly installments">48 monthly installments of approximately $15,000. The Company also pays collateral monitoring fees of <span id="xdx_906_ecustom--DebtInstrumentCollateralMonitoringFeePercent_pid_dp_uPure_c20210930__20210930__us-gaap--TypeOfArrangementAxis__custom--LineFinancialAgreementMember_z7QB75ykSIl6" title="Monitoring fees percentage">4.62% of the eligible accounts receivable, inventory, and equipment supporting both facilities. Originally maturing September 30, 2023, the Senior Facilities were extended to April 30, 2027 pursuant to a Fifth Amendment executed on September 30, 2025, which also increased the revolving commitment from $<span id="xdx_90F_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_iI_pn5n6_c20250930__us-gaap--TypeOfArrangementAxis__custom--LineFinancialAgreementMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__srt--RangeAxis__srt--MinimumMember_z4BHoJ6U3j42" title="Line of credit balance">6.0 million to $<span id="xdx_905_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_iI_pn5n6_c20250930__us-gaap--TypeOfArrangementAxis__custom--LineFinancialAgreementMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__srt--RangeAxis__srt--MaximumMember_zcER7W90T8ja" title="Revolving commitment amount">7.0 million and added a <span id="xdx_906_ecustom--DebtInstrumentRenewalFeePercentage_iI_pid_dp_uPure_c20250930__us-gaap--TypeOfArrangementAxis__custom--LineFinancialAgreementMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zPcDIEOUntpe" title="Renewal fee percentage">0.75% renewal fee, payable in two equal installments in October 2025 and September 2026. A $<span id="xdx_904_eus-gaap--DebtInstrumentFeeAmount_iI_c20250930__us-gaap--TypeOfArrangementAxis__custom--LineFinancialAgreementMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zDZtZCaUEIo6" title="Commitment fee">12,500 commitment fee was also incurred. All other material terms, including borrowing base, collateral, and covenants, remained unchanged. The facility automatically renews for successive one-year periods unless either party provides written notice of termination not less than 90 days prior to the end of the then-current term. The Company may prepay the Term Loan Facility (together with accrued interest and any applicable prepayment fee) in whole, but not in part, upon at least 60 days’ prior written notice. <span id="xdx_904_eus-gaap--DebtInstrumentCovenantDescription_c20260101__20260630__us-gaap--TypeOfArrangementAxis__custom--LineFinancialAgreementMember_zkyAcvlqhPB9" title="Debt instrument, covenant description">The Agreement requires the Company to maintain minimum tangible net worth of $4.0 million, subject to adjustment by the Lender. The Company was in compliance with this covenant as of June 30, 2026 and 2025. The Agreement also limits additional indebtedness, liens, dividends, mergers, and annual capital expenditures exceeding $1.0 million. As of June 30, 2026 and December 31, 2025, the term loan balance was approximately $<span id="xdx_902_eus-gaap--LongTermDebt_iI_pn4n6_c20260630__us-gaap--CreditFacilityAxis__custom--TermLoanMember__us-gaap--TypeOfArrangementAxis__custom--LineFinancialAgreementMember_zte4T9hrCY91" title="Loan balance">0.45 and $<span id="xdx_90E_eus-gaap--LongTermDebt_iI_pn5n6_c20251231__us-gaap--TypeOfArrangementAxis__custom--LineFinancialAgreementMember__us-gaap--CreditFacilityAxis__custom--TermLoanMember_zDW0ZX1TKeN" title="Loan balance">0.5 million, respectively, and the revolving balance was $<span id="xdx_90E_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_iI_pn5n6_c20260630__us-gaap--TypeOfArrangementAxis__custom--LineFinancialAgreementMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zkBKkLGoyU0h" title="Line of credit balance">4.6 million and $<span id="xdx_904_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_iI_pn5n6_c20251231__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--TypeOfArrangementAxis__custom--LineFinancialAgreementMember_z88gu8GPwIwi" title="Line of credit balance">6.8 million, respectively. There was $<span id="xdx_901_eus-gaap--LineOfCreditFacilityRemainingBorrowingCapacity_iI_pn5n6_c20260630__us-gaap--TypeOfArrangementAxis__custom--LineFinancialAgreementMember__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember_zVlRTigYYPYg" title="Line of credit, available amount">2.4 million remaining available for borrowing under the Revolving Credit Facility as of June 30, 2026. Notes payable, Related Party The Company is party to a note payable to John H. Schwan, Director and former Chairman of the Board, for an initial amount of $1.3 million as of December 31, 2023 and an interest rate of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JohnHSchwanMember_zbbgUpoO5lll" title="Interest rate">6%. The Company repaid $1 million to Mr. Schwan during January 2024. The parties agreed to the payment of the remaining $0.3 million at a future date to be determined. This related party note payable is subordinate to the Senior Facilities.

7000000

731250

0.0782 0.1457 0.0145 0.082

48 monthly installments

15000

0.0462

2023-09-30

2027-04-30

6000000.0

7000000.0

0.0075

12500

The Agreement requires the Company to maintain minimum tangible net worth of $4.0 million, subject to adjustment by the Lender. The Company was in compliance with this covenant as of June 30, 2026 and 2025. The Agreement also limits additional indebtedness, liens, dividends, mergers, and annual capital expenditures exceeding $1.0 million.

450000

500000

4600000

6800000

2400000

1300000

0.06

1000000

300000

Note 4 - Shareholders’ Equity Series E Convertible Preferred Stock The Company’s Articles of Incorporation, as amended, authorized the issuance of 130,000 shares of Series E Convertible Preferred Stock (“Series E Preferred”). The Series E Preferred can be converted to common stock, at the option of the holder, at the rate of ten (10) shares of the company’s common stock, no par value. Holders of the Series E Preferred will be entitled to receive quarterly dividends at the annual rate of <span id="xdx_900_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20260101__20260630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zTCtUAHHTgW9" title="Preferred stock, dividend rate">8.5% of the stated value ($10 per share) and have a liquidation preference over common stock. Such dividends may be paid in cash or otherwise based on the terms of the agreement. Accrued dividends of $261,000 and $205,000 were recorded as of June 30, 2026 and December 31, 2025, respectively. In addition, warrants to purchase <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zogtm9noXJDg" title="Warrants to purchase shares">36,140 shares of the Company’s common stock were issued with respect to this transaction and are equity classified instruments. These warrants are exercisable until March 2027. Series F Convertible Preferred Stock The Company’s Articles of Incorporation, as amended, authorized the issuance of 70,000 shares of Series F Preferred. The Series F Preferred can be converted to common stock, at the option of the holder, at the rate of ten (10) shares of the Company’s common stock, no par value. Holders of the Series F Preferred will be entitled to receive quarterly dividends at the annual rate of <span id="xdx_900_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20260101__20260630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_zgibrDUhhvAk" title="Preferred stock, dividend rate">8.5% of the stated value ($10 per share) and have a liquidation preference over common stock. Such dividends may be paid in cash or stock, at the Company’s discretion, based on the terms of the agreement. Accrued dividends of $140,000 and $110,000 were recorded as of June 30, 2026 and December 31, 2025, respectively. In addition, warrants to purchase <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_zGZYwEj412F1" title="Warrants to purchase shares">19,460 shares of the Company’s common stock were issued with respect to this transaction and are equity classified instruments. These warrants are exercisable until March 2027. Warrants As described above, in connection with the Series E and F convertible preferred equity issuances, a total of <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zgUhtS2dAZnc" title="Warrants issued to purchase common stock">55,600 warrants were issued, exercisable for the Company’s common stock at the lower of $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zE13BJezNq56" title="Exercise price of warrants">15.2 per share or <span id="xdx_90A_ecustom--PercentageOfVolumeWeightedAveragePercentage_iI_pid_dp_uPure_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6RXqQctvLj4" title="Percentage of variable price on VWAP">90% of the 10 day VWAP. A summary of the Company’s stock warrant activity is as follows: Schedule of Company’s Stock Warrant Activity <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares under Option (warrant)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Balance at December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpIBTCdOXvM3" style="width: 16%; text-align: right" title="Shares under Option (warrant), beginning balance">55,600</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zKIrZJfz3cNf" style="width: 16%; text-align: right" title="Weighted Average Exercise Price, beginning balance">15.2</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zO4G8wDAvDfk" style="text-align: right" title="Shares under Option (warrant), Granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zkJ3yK2fYpDb" style="text-align: right" title="Weighted Average Exercise Price, Granted">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Cancelled/Expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zEiP0dPfqw76" style="text-align: right" title="Shares under Option (warrant), Cancelled/Expired">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledAndExpiredWeightedAverageExercisePrice_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zXKWMrcJrXK8" style="text-align: right" title="Weighted Average Exercise Price, Cancelled/Expired">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Exercised/Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zkskpIb1iGPc" style="text-align: right" title="Shares under Option (warrant), Exercised/Issued">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zi0dKgVJuq91" style="text-align: right" title="Weighted Average Exercise Price, Exercised/Issued">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Outstanding at June 30, 2026</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z2u872Gtesp8" style="text-align: right" title="Shares under Option (warrant), ending balance">55,600</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z87q1svwdfD7" style="text-align: right" title="Weighted Average Exercise Price, ending balance">15.2</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Exercisable at June 30, 2026</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zWHaOi4OybJ5" style="text-align: right" title="Shares under Option (warrant), Exercisable shares">55,600</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zABGNVxZqc1g" style="text-align: right" title="Weighted Average Exercise Price, Exercisable">15.2</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_89B_ecustom--ScheduleOfReservedSharesOfCommonStockExerciseOfWarrantAndPreferredStockTableTextBlock_zJCoM85TIfC5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">As of June 30, 2026 the Company reserved the following shares of its common stock for the exercise of warrants, and preferred stock: Schedule of Reserved Shares For Exercise of Warrants and Preferred Stock <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify; padding-bottom: 1pt">2025 Common Stock Warrants</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"><span id="xdx_900_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwoThousandAndTwentyFiveCommonStockWarrantsMember_zKfFa6ZAVaP6" title="Shares reserved for warrants">55,600</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Shares reserved for warrants as of June 30, 2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">55,600</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: justify">Security</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Preferred Shares Authorized/ Outstanding</td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center">Conversion Ratio</td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Common Shares Reserved</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: justify">Series E Preferred Stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zIylIpu9sD27" title="Preferred stock, shares outstanding">130,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td id="xdx_981_eus-gaap--PreferredStockConvertibleConversionRatio_iI_uPure_c20260630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zIGpLztBXN91" style="width: 16%; text-align: right" title="Preferred stock, conversion ratio">10:1</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20260630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zZU108ywRpf1" style="width: 14%; text-align: right" title="Shares reserved">1,300,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Series F Preferred Stock</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_zcrig0uAu3fi" title="Preferred stock, shares outstanding">70,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td id="xdx_98A_eus-gaap--PreferredStockConvertibleConversionRatio_iI_uPure_c20260630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_zpAJFY8yWY0h" style="text-align: right; padding-bottom: 1pt" title="Preferred stock, conversion ratio">10:1</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20260630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_z9rRAMYtXOK6" style="border-bottom: Black 1pt solid; text-align: right" title="Shares reserved">700,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Shares reserved for Preferred Stock as of June 30, 2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zngIZsQdz3y9" style="text-align: right" title="Common shares reserved">2,000,000</td><td style="text-align: left"> </td></tr> </table> In total, <span id="xdx_909_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesEandSeriesFPreferredStockMember_ziZp5bQ1ELW8" title="Shares reserved for warrants">2,055,600 shares of common stock were reserved for issuance upon exercise of outstanding warrants and conversion of the Series E and Series F Preferred Stock as of June 30, 2026 Restricted Stock Awards <p id="xdx_896_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_ziL1WldlkgN8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">Restricted Stock Units, Performance-Based Restricted Stock Units and Restricted Stock Awards: Aggregated information regarding RSUs, PSUs and RSAs granted under the Plan is summarized below: Summary of Aggregated Information Regarding RSUs, PSUs and RSAs granted <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">RSUs, PSUs & RSAs</td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Grant- Date Fair Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify; padding-bottom: 2.5pt">Outstanding, unvested at December 31, 2025</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20260101__20260630__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember_zxsnwFGeng82" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="RSUs, PSUs & RSAs, beginning balance">20,158</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20260101__20260630__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember_zKS1cBlyZUri" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Weighted Average Grant-Date Fair Value, beginning balance">3.63</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20260101__20260630__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember_zaOdZ4N8HwT2" style="text-align: right" title="RSUs, PSUs & RSAs, Granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20260101__20260630__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember_z2bjyvAIsGJ4" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Granted">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pid_di_c20260101__20260630__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember_zFYJKhAnLxX8" style="text-align: right" title="RSUs, PSUs & RSAs, Vested">(8,104</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20260101__20260630__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember_zz2hF7GwUAK5" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested">6.47</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pid_di_c20260101__20260630__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember_zpsznZtS8857" style="border-bottom: Black 1pt solid; text-align: right" title="RSUs, PSUs & RSAs, Forfeited">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20260101__20260630__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember_zoJI60XZO9y3" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Outstanding, unvested at June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20260101__20260630__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember_zZSnszXu8i0d" style="border-bottom: Black 2.5pt double; text-align: right" title="RSUs, PSUs & RSAs, ending balance">12,054</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20260101__20260630__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember_z4kpdbGJ2yd8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant-Date Fair Value, ending balance">3.01</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Differences between amount of vested awards and shares of common stock issued are attributable to timing differences.

130000

The Series E Preferred can be converted to common stock, at the option of the holder, at the rate of ten (10) shares of the company’s common stock, no par value.

0.085

261000

205000

36140

70000

The Series F Preferred can be converted to common stock, at the option of the holder, at the rate of ten (10) shares of the Company’s common stock, no par value

0.085

140000

110000

19460

55600

15.2

0.90

A summary of the Company’s stock warrant activity is as follows: Schedule of Company’s Stock Warrant Activity <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares under Option (warrant)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Balance at December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpIBTCdOXvM3" style="width: 16%; text-align: right" title="Shares under Option (warrant), beginning balance">55,600</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zKIrZJfz3cNf" style="width: 16%; text-align: right" title="Weighted Average Exercise Price, beginning balance">15.2</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zO4G8wDAvDfk" style="text-align: right" title="Shares under Option (warrant), Granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedWeightedAverageExercisePrice_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zkJ3yK2fYpDb" style="text-align: right" title="Weighted Average Exercise Price, Granted">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Cancelled/Expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zEiP0dPfqw76" style="text-align: right" title="Shares under Option (warrant), Cancelled/Expired">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelledAndExpiredWeightedAverageExercisePrice_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zXKWMrcJrXK8" style="text-align: right" title="Weighted Average Exercise Price, Cancelled/Expired">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Exercised/Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zkskpIb1iGPc" style="text-align: right" title="Shares under Option (warrant), Exercised/Issued">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zi0dKgVJuq91" style="text-align: right" title="Weighted Average Exercise Price, Exercised/Issued">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Outstanding at June 30, 2026</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z2u872Gtesp8" style="text-align: right" title="Shares under Option (warrant), ending balance">55,600</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z87q1svwdfD7" style="text-align: right" title="Weighted Average Exercise Price, ending balance">15.2</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Exercisable at June 30, 2026</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zWHaOi4OybJ5" style="text-align: right" title="Shares under Option (warrant), Exercisable shares">55,600</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zABGNVxZqc1g" style="text-align: right" title="Weighted Average Exercise Price, Exercisable">15.2</td><td style="text-align: left"> </td></tr> </table>

55600

15.2

55600

15.2 55600 15.2 <p id="xdx_89B_ecustom--ScheduleOfReservedSharesOfCommonStockExerciseOfWarrantAndPreferredStockTableTextBlock_zJCoM85TIfC5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">As of June 30, 2026 the Company reserved the following shares of its common stock for the exercise of warrants, and preferred stock: Schedule of Reserved Shares For Exercise of Warrants and Preferred Stock <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify; padding-bottom: 1pt">2025 Common Stock Warrants</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"><span id="xdx_900_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20260630__us-gaap--StatementEquityComponentsAxis__custom--TwoThousandAndTwentyFiveCommonStockWarrantsMember_zKfFa6ZAVaP6" title="Shares reserved for warrants">55,600</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Shares reserved for warrants as of June 30, 2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">55,600</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: justify">Security</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Preferred Shares Authorized/ Outstanding</td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center">Conversion Ratio</td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Common Shares Reserved</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: justify">Series E Preferred Stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zIylIpu9sD27" title="Preferred stock, shares outstanding">130,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td id="xdx_981_eus-gaap--PreferredStockConvertibleConversionRatio_iI_uPure_c20260630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zIGpLztBXN91" style="width: 16%; text-align: right" title="Preferred stock, conversion ratio">10:1</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20260630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zZU108ywRpf1" style="width: 14%; text-align: right" title="Shares reserved">1,300,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Series F Preferred Stock</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_zcrig0uAu3fi" title="Preferred stock, shares outstanding">70,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td id="xdx_98A_eus-gaap--PreferredStockConvertibleConversionRatio_iI_uPure_c20260630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_zpAJFY8yWY0h" style="text-align: right; padding-bottom: 1pt" title="Preferred stock, conversion ratio">10:1</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20260630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_z9rRAMYtXOK6" style="border-bottom: Black 1pt solid; text-align: right" title="Shares reserved">700,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Shares reserved for Preferred Stock as of June 30, 2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zngIZsQdz3y9" style="text-align: right" title="Common shares reserved">2,000,000</td><td style="text-align: left"> </td></tr> </table>

55600

130000

1300000

70000

700000

2000000

2055600

<p id="xdx_896_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_ziL1WldlkgN8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">Restricted Stock Units, Performance-Based Restricted Stock Units and Restricted Stock Awards: Aggregated information regarding RSUs, PSUs and RSAs granted under the Plan is summarized below: Summary of Aggregated Information Regarding RSUs, PSUs and RSAs granted <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">RSUs, PSUs & RSAs</td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Grant- Date Fair Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify; padding-bottom: 2.5pt">Outstanding, unvested at December 31, 2025</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20260101__20260630__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember_zxsnwFGeng82" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="RSUs, PSUs & RSAs, beginning balance">20,158</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20260101__20260630__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember_zKS1cBlyZUri" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Weighted Average Grant-Date Fair Value, beginning balance">3.63</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20260101__20260630__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember_zaOdZ4N8HwT2" style="text-align: right" title="RSUs, PSUs & RSAs, Granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20260101__20260630__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember_z2bjyvAIsGJ4" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Granted">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pid_di_c20260101__20260630__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember_zFYJKhAnLxX8" style="text-align: right" title="RSUs, PSUs & RSAs, Vested">(8,104</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20260101__20260630__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember_zz2hF7GwUAK5" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested">6.47</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pid_di_c20260101__20260630__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember_zpsznZtS8857" style="border-bottom: Black 1pt solid; text-align: right" title="RSUs, PSUs & RSAs, Forfeited">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20260101__20260630__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember_zoJI60XZO9y3" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Outstanding, unvested at June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20260101__20260630__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember_zZSnszXu8i0d" style="border-bottom: Black 2.5pt double; text-align: right" title="RSUs, PSUs & RSAs, ending balance">12,054</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20260101__20260630__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember_z4kpdbGJ2yd8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant-Date Fair Value, ending balance">3.01</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

20158

3.63

8104

6.47

12054

3.01

Note 5 - Legal Proceedings The Company may be party to certain lawsuits or claims arising in the normal course of business. The ultimate outcome of these matters is unknown but, in the opinion of management, we do not believe any of these proceedings will have, individually or in the aggregate, a material adverse effect upon our financial condition, cash flows or future results of operation.

Note 6 – Inventories Schedule of Inventories <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20260630_zRUPefQ4uW83" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2026</td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20251231_znqTQ7COEaNb" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_406_eus-gaap--InventoryRawMaterials_iI_maINzkjA_zd47HUYw3kOd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">883,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">749,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--InventoryWorkInProcess_iI_maINzkjA_zuD7jYGDUuM4" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Work in process</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,489,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,569,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryFinishedGoods_iI_maINzkjA_zDpDicNqFtE5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4,455,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,420,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--InventoryNet_iTI_mtINzkjA_zcHGCd8MF0ef" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total inventories</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,827,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,738,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

Schedule of Inventories <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20260630_zRUPefQ4uW83" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2026</td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20251231_znqTQ7COEaNb" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_406_eus-gaap--InventoryRawMaterials_iI_maINzkjA_zd47HUYw3kOd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">883,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">749,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--InventoryWorkInProcess_iI_maINzkjA_zuD7jYGDUuM4" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Work in process</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,489,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,569,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryFinishedGoods_iI_maINzkjA_zDpDicNqFtE5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4,455,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,420,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--InventoryNet_iTI_mtINzkjA_zcHGCd8MF0ef" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total inventories</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,827,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,738,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

883000

749000

2489000

2569000

4455000

5420000

7827000

8738000

Note 7 - Concentration of Credit Risk Concentration of credit risk with respect to trade accounts receivable is generally limited due to the large number of entities comprising the Company’s customer base. The Company performs ongoing credit evaluations and provides an allowance for potential credit losses against the portion of accounts receivable which is estimated to be uncollectible. Such losses have historically been within management’s expectations. During the three and six months ended June 30, 2026 and 2025, there were two customers whose purchases represented more than 10% of the Company’s consolidated net sales. Sales to these customers for the three and six months ended June 30, 2026 and 2025 are as follows: Schedule of Concentration Risk <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold; text-align: justify">Customer</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Sales</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">% of Net Sales</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Sales</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">% of Net Sales</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: justify">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20260401__20260630__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zA7aelGmBD2c" style="width: 12%; text-align: right" title="Net Sales">1,805,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20260401__20260630__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z4QrlAMyfL23" style="width: 12%; text-align: right" title="Percentage of Net Sales">44</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20250401__20250630__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zGPeZjM05w9e" style="width: 12%; text-align: right" title="Net Sales">2,153,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20250401__20250630__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z7KlJ6sVfyo6" style="width: 12%; text-align: right" title="Percentage of Net Sales">38</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20260401__20260630__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z94PeWBLdYO" style="text-align: right" title="Net Sales">1,536,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20260401__20260630__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zYBlXWyZ3jS5" style="text-align: right" title="Percentage of Net Sales">37</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20250401__20250630__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zNF5CieVxSzh" style="text-align: right" title="Net Sales">2,456,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20250401__20250630__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zzVkBmzMMB7k" style="text-align: right" title="Percentage of Net Sales">44</td><td style="text-align: left">%</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold; text-align: justify">Customer</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Sales</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">% of Net Sales</td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Sales</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">% of Net Sales</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: justify">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20260101__20260630__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zVbTJbe8pHHg" style="width: 12%; text-align: right" title="Net Sales">4,183,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20260101__20260630__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z9CJTzAWNrm6" style="width: 12%; text-align: right" title="Percentage of Net Sales">41</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20250101__20250630__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zB2Y64U7DkK1" style="width: 12%; text-align: right" title="Net Sales">5,244,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20250101__20250630__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z4KswMwerJV5" style="width: 12%; text-align: right" title="Percentage of Net Sales">50</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20260101__20260630__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zgbectjtbK6j" style="text-align: right" title="Net Sales">4,504,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20260101__20260630__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z6RG4AvWd4Gc" style="text-align: right" title="Percentage of Net Sales">44</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20250101__20250630__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zn296DGlLXVk" style="text-align: right" title="Net Sales">2,979,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20250101__20250630__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z0P8PLRlDdd6" style="text-align: right" title="Percentage of Net Sales">28</td><td style="text-align: left">%</td></tr> </table> As of June 30, 2026, the outstanding accounts receivable balance from these two customers was $3.2 million.

Schedule of Concentration Risk <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold; text-align: justify">Customer</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Sales</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">% of Net Sales</td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Sales</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">% of Net Sales</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: justify">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20260401__20260630__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zA7aelGmBD2c" style="width: 12%; text-align: right" title="Net Sales">1,805,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20260401__20260630__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z4QrlAMyfL23" style="width: 12%; text-align: right" title="Percentage of Net Sales">44</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20250401__20250630__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zGPeZjM05w9e" style="width: 12%; text-align: right" title="Net Sales">2,153,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20250401__20250630__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z7KlJ6sVfyo6" style="width: 12%; text-align: right" title="Percentage of Net Sales">38</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20260401__20260630__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z94PeWBLdYO" style="text-align: right" title="Net Sales">1,536,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20260401__20260630__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zYBlXWyZ3jS5" style="text-align: right" title="Percentage of Net Sales">37</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20250401__20250630__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zNF5CieVxSzh" style="text-align: right" title="Net Sales">2,456,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20250401__20250630__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zzVkBmzMMB7k" style="text-align: right" title="Percentage of Net Sales">44</td><td style="text-align: left">%</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold; text-align: justify">Customer</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Sales</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">% of Net Sales</td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Sales</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">% of Net Sales</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: justify">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20260101__20260630__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zVbTJbe8pHHg" style="width: 12%; text-align: right" title="Net Sales">4,183,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20260101__20260630__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z9CJTzAWNrm6" style="width: 12%; text-align: right" title="Percentage of Net Sales">41</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20250101__20250630__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zB2Y64U7DkK1" style="width: 12%; text-align: right" title="Net Sales">5,244,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20250101__20250630__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z4KswMwerJV5" style="width: 12%; text-align: right" title="Percentage of Net Sales">50</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer B</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20260101__20260630__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zgbectjtbK6j" style="text-align: right" title="Net Sales">4,504,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20260101__20260630__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z6RG4AvWd4Gc" style="text-align: right" title="Percentage of Net Sales">44</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20250101__20250630__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zn296DGlLXVk" style="text-align: right" title="Net Sales">2,979,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20250101__20250630__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z0P8PLRlDdd6" style="text-align: right" title="Percentage of Net Sales">28</td><td style="text-align: left">%</td></tr> </table>

1805000

0.44

2153000

0.38

1536000

0.37

2456000

0.44

4183000

0.41

5244000

0.50

4504000

0.44

2979000

0.28

3200000

Note 8 - Related Party Transactions Ms. Jana M. Schwan is the Company’s Chief Executive Officer. Her father, John H. Schwan, held several positions with the Company over many years, most recently as Chairman of the Board until June 2020 as discussed in Note 3, Mr. John H. Schwan was owed approximately $0.3 million as of both June 30, 2026 and December 31, 2025, in a note from the Company. Icy Mellon LLC, the landlord of the Company’s Barrington Facility, is a shareholder of the Company. The Company’s Vice President – Strategy and Business Development also serves as a Manager of Icy Mellon LLC. On January 13, 2025, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250113__20250113__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--IcyMelonLLCMember_zyeg3qm2f52" title="Number of common stock issued">27,604 shares of common stock with an aggregate fair value of approximately $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250113__20250113__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--IcyMelonLLCMember_zp8cZRSp3NLe" title="Fair value of common stock issued">182,000 to settle rent payable that had been included in accrued expenses as of December 31, 2024. Rent expense related to Barrington facility was approximately $144,000 and $139,000 for the three months ended June 30, 2026, and 2025, respectively. As of June 30, 2026 and December 31, 2025, amounts due to Icy Mellon LLC totaled approximately $283,000 and $234,000. During the three months ended June 30, 2026, the Company received a cash advance of $75,000 from Icy Mellon LLC. The Company had previously received cash advances totaling $150,000 from Icy Mellon LLC during 2025, resulting in aggregate advances of $225,000 held as of June 30, 2026. The advances were provided pending the execution of a definitive agreement, and the specific terms and purpose of the advances have not yet been finalized. Accordingly, the advances have been recorded as advances from investor on the Company’s condensed consolidated balance sheets.

300000

27604

182000

144000

139000

283000

234000

75000

150000

225000

Note 9 - Leases We enter into lease contracts for certain of our facilities at two locations. Our leases have remaining lease terms of 2 two and five years. The weighted average discount rate for our operating leases is 14.05%. We calculated the weighted-average discount rate using incremental borrowing rates, which equal the rates of interest that we would pay to borrow funds on a fully collateralized basis over a similar term. At June 30, 2026, maturities of operating lease liabilities are as follows: Schedule of Maturities of Operating Lease Liabilities <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20260630_zEYAffcHpI01" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_maLOLLPzoam_zv0Q730Nj1Ld" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify">2026</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">527,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzoam_zth3x8Tvvnyf" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,083,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzoam_zaqWlniT7Fr3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2028</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,119,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzoam_zbUkytOLQkMc" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2029</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">627,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_maLOLLPzoam_zz91ydq6DF4c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2030</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">646,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_iI_maLOLLPzoam_zxB5xy31fImi" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Thereafter</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">217,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzoam_zW3BpZZnnxv5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">Total Lease Payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,219,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_z5wG8o98qGB9" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1pt">Less: Imputed interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,034,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseLiability_iI_z0sSbWExBbr4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1pt">Total Lease Liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,185,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table>

P2Y

P5Y

0.1405

At June 30, 2026, maturities of operating lease liabilities are as follows: Schedule of Maturities of Operating Lease Liabilities <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20260630_zEYAffcHpI01" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_maLOLLPzoam_zv0Q730Nj1Ld" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify">2026</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">527,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzoam_zth3x8Tvvnyf" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,083,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzoam_zaqWlniT7Fr3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2028</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,119,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzoam_zbUkytOLQkMc" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2029</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">627,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_maLOLLPzoam_zz91ydq6DF4c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2030</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">646,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_iI_maLOLLPzoam_zxB5xy31fImi" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Thereafter</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">217,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzoam_zW3BpZZnnxv5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify">Total Lease Payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,219,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_z5wG8o98qGB9" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1pt">Less: Imputed interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,034,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseLiability_iI_z0sSbWExBbr4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: justify; padding-bottom: 1pt">Total Lease Liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,185,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table>

527000

1083000

1119000

627000

646000

217000

4219000

1034000

3185000

false false false false false false